Avid Bioservices Inc
NASDAQ:CDMO
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.64
12.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CDMO stock under the Base Case scenario is 18.42 USD. Compared to the current market price of 12.3 USD, Avid Bioservices Inc is Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Avid Bioservices Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CDMO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Avid Bioservices Inc
Balance Sheet Decomposition
Avid Bioservices Inc
Current Assets | 103.6m |
Cash & Short-Term Investments | 33.4m |
Receivables | 35.2m |
Other Current Assets | 35.1m |
Non-Current Assets | 231m |
PP&E | 226.4m |
Other Non-Current Assets | 4.7m |
Current Liabilities | 71.1m |
Accounts Payable | 20m |
Accrued Liabilities | 7m |
Other Current Liabilities | 44.1m |
Non-Current Liabilities | 204.9m |
Long-Term Debt | 160.6m |
Other Non-Current Liabilities | 44.3m |
Earnings Waterfall
Avid Bioservices Inc
Revenue
|
180.1m
USD
|
Cost of Revenue
|
-167.1m
USD
|
Gross Profit
|
13m
USD
|
Operating Expenses
|
-36.1m
USD
|
Operating Income
|
-23m
USD
|
Other Expenses
|
-123.3m
USD
|
Net Income
|
-146.3m
USD
|
Free Cash Flow Analysis
Avid Bioservices Inc
USD | |
Free Cash Flow | USD |
Avid Bioservices started fiscal 2025 robustly, reporting a 6% increase in revenues year-over-year to $40.2 million, driven primarily by higher process development revenues. Gross profit also rose to $5.7 million, representing a 14% gross margin, up from 11% the previous year. Though facing a net loss of $5.5 million, the company signed $66 million in new project agreements, achieving a record backlog of $219 million. This includes significant contributions from new customers, particularly in late-stage programs, projecting long-term revenue growth and improved margins. The team remains optimistic about continuing growth and operational improvements through the rest of the year.
What is Earnings Call?
CDMO Profitability Score
Profitability Due Diligence
Avid Bioservices Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Avid Bioservices Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
CDMO Solvency Score
Solvency Due Diligence
Avid Bioservices Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Score
Avid Bioservices Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CDMO Price Targets Summary
Avid Bioservices Inc
According to Wall Street analysts, the average 1-year price target for CDMO is 13.01 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.
Dividends
Current shareholder yield for CDMO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CDMO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
Contact
IPO
Employees
Officers
The intrinsic value of one CDMO stock under the Base Case scenario is 18.42 USD.
Compared to the current market price of 12.3 USD, Avid Bioservices Inc is Undervalued by 33%.